Thomas Scheinok

Thomas Scheinok is a Research Fellow at the Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, with affiliations to Clinical Sciences UZB and expertise in Neurology and Artificial Intelligence supported Modelling in Clinical Sciences.

• Education:
  • Master's Thesis: NIHSS subitems as predictors of post-stroke delirium (2020)
  • Master's Thesis: Predictors of post-stroke-delirium (2020)
  • Master's Thesis: Non-invasive transcranial electrical stimulation to enhance remyelination in the cuprizone model of Multiple Sclerosis (2023)

His research focuses on delirium, stroke, multiple sclerosis, and remyelination, utilizing techniques like bioelectrical impedance analysis and non-invasive neuromodulation. Recent work explores the role of neutrophil-to-lymphocyte ratios in predicting delirium and the therapeutic potential of transcranial alternating current stimulation in demyelinating diseases.

Key publications examine stroke outcome prediction, fluid overload in ICU, and neuromodulation for remyelination. His research combines clinical neuroscience with computational modeling and biomarker identification.

• Scientific Awards:
  • International scholarship to the American Academy of Neurology 2025 (Fellowship awarded competitively)

Thomas actively participates in academic committees, conferences, and peer-review activities, including chairing sessions at the European Academy of Neurology and BNS Spring Meeting 2025. He contributes to advancing understanding of delirium pathophysiology and remyelination therapies.